MEOX2 and glioblastoma: In gliomas, Bao et al. analyzed TCGA dataset for 117 glioblastomas (GBM) with mesenchymal subtype and identified a molecular signature of 17 transcription factors, including MEOX2, which correlated with overall survival [13].